Follow the people · Insider
Kevin Feeley
Kevin Feeley files insider transactions with the SEC as a chief financial officer of GeneDx Holdings (WGS). We hold 11 disclosed purchases and sales filed since 8 September 2022, 3 of them in the last 90 days.
- Files forWGS
- Disclosed buys and sells11 in all, 3 in the last 90 days
- Last disclosure3 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 March 2023 — 1 September 2026Chief Financial Officer · GeneDx Holdings (WGS)282 Form 4 lines · source: SEC Form 4
- Filed 1 September 2022 — 9 December 2022Chief Financial Officer · Sema4 Holdings (SMFR)6 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 717 shares of GeneDx HoldingsSEC Form 43 September 2026Class A Common Stock · traded 1 September 2026 · filed 3 September 2026
- ▼ sold on the open market 372 shares of GeneDx HoldingsSEC Form 43 September 2026Class A Common Stock · traded 1 September 2026 · filed 3 September 2026
- exercised options over 717 shares of GeneDx Holdings (a derivative holding)SEC Form 43 September 2026Restricted Stock Unit · traded 1 September 2026 · filed 3 September 2026
- exercised options over 7,197 shares of GeneDx HoldingsSEC Form 418 June 2026Class A Common Stock · traded 16 June 2026 · filed 18 June 2026
- ▼ sold on the open market 760 shares of GeneDx HoldingsSEC Form 418 June 2026Class A Common Stock · traded 16 June 2026 · filed 18 June 2026
- ▼ sold on the open market 2,106 shares of GeneDx HoldingsSEC Form 418 June 2026Class A Common Stock · traded 16 June 2026 · filed 18 June 2026
- ▼ sold on the open market 863 shares of GeneDx HoldingsSEC Form 418 June 2026Class A Common Stock · traded 16 June 2026 · filed 18 June 2026
- exercised options over 7,197 shares of GeneDx Holdings (a derivative holding)SEC Form 418 June 2026Restricted Stock Unit · traded 16 June 2026 · filed 18 June 2026
- exercised options over 2,462 shares of GeneDx HoldingsSEC Form 411 June 2026Class A Common Stock · traded 9 June 2026 · filed 11 June 2026
- ▼ sold on the open market 1,266 shares of GeneDx HoldingsSEC Form 411 June 2026Class A Common Stock · traded 9 June 2026 · filed 11 June 2026
- exercised options over 2,462 shares of GeneDx Holdings (a derivative holding)SEC Form 411 June 2026Restricted Stock Unit · traded 9 June 2026 · filed 11 June 2026
- exercised options over 717 shares of GeneDx HoldingsSEC Form 43 June 2026Class A Common Stock · traded 1 June 2026 · filed 3 June 2026
- ▼ sold on the open market 369 shares of GeneDx HoldingsSEC Form 43 June 2026Class A Common Stock · traded 1 June 2026 · filed 3 June 2026
- exercised options over 717 shares of GeneDx Holdings (a derivative holding)SEC Form 43 June 2026Restricted Stock Unit · traded 1 June 2026 · filed 3 June 2026
- exercised options over 754 shares of GeneDx HoldingsSEC Form 41 May 2026Class A Common Stock · traded 29 April 2026 · filed 1 May 2026
- ▼ sold on the open market 392 shares of GeneDx HoldingsSEC Form 41 May 2026Class A Common Stock · traded 29 April 2026 · filed 1 May 2026
- exercised options over 754 shares of GeneDx Holdings (a derivative holding)SEC Form 41 May 2026Restricted Stock Unit · traded 29 April 2026 · filed 1 May 2026
- exercised options over 16,250 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 2,485 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 961 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- exercised options over 16,250 shares of GeneDx Holdings (a derivative holding)SEC Form 430 March 2026Restricted Stock Unit · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 2,520 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 995 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 1,857 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- exercised options over 16,250 shares of GeneDx Holdings (a derivative holding)SEC Form 430 March 2026Restricted Stock Unit · traded 26 March 2026 · filed 30 March 2026
- exercised options over 16,250 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 2,485 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 961 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 2,520 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 995 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 1,857 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- exercised options over 3,815 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 7,197 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 2,384 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 3,815 shares of GeneDx Holdings (a derivative holding)SEC Form 417 March 2026Restricted Stock Unit · traded 15 March 2026 · filed 17 March 2026
- exercised options over 7,197 shares of GeneDx Holdings (a derivative holding)SEC Form 417 March 2026Restricted Stock Unit · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 3,065 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 257 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 3,815 shares of GeneDx Holdings (a derivative holding)SEC Form 417 March 2026Restricted Stock Unit · traded 15 March 2026 · filed 17 March 2026
- exercised options over 7,197 shares of GeneDx Holdings (a derivative holding)SEC Form 417 March 2026Restricted Stock Unit · traded 16 March 2026 · filed 17 March 2026
- exercised options over 3,815 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 7,197 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 2,384 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 3,065 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 257 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 2,462 shares of GeneDx HoldingsSEC Form 411 March 2026Class A Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 1,280 shares of GeneDx HoldingsSEC Form 411 March 2026Class A Common Stock · traded 9 March 2026 · filed 11 March 2026
- exercised options over 2,462 shares of GeneDx Holdings (a derivative holding)SEC Form 411 March 2026Restricted Stock Unit · traded 9 March 2026 · filed 11 March 2026
- exercised options over 2,462 shares of GeneDx Holdings (a derivative holding)SEC Form 411 March 2026Restricted Stock Unit · traded 9 March 2026 · filed 11 March 2026
- exercised options over 2,462 shares of GeneDx HoldingsSEC Form 411 March 2026Class A Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 1,280 shares of GeneDx HoldingsSEC Form 411 March 2026Class A Common Stock · traded 9 March 2026 · filed 11 March 2026
- was granted 1,986 shares of GeneDx HoldingsSEC Form 49 March 2026Class A Common Stock · traded 6 March 2026 · filed 9 March 2026
- was granted 1,986 shares of GeneDx HoldingsSEC Form 49 March 2026Class A Common Stock · traded 6 March 2026 · filed 9 March 2026
- was granted 15,262 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- ▼ sold on the open market 1,424 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- ▼ sold on the open market 2,543 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- was granted 10,865 shares of GeneDx Holdings (a derivative holding)SEC Form 45 March 2026Restricted Stock Unit · traded 3 March 2026 · filed 5 March 2026
- ▼ sold on the open market 2,220 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- was granted 10,865 shares of GeneDx Holdings (a derivative holding)SEC Form 45 March 2026Restricted Stock Unit · traded 3 March 2026 · filed 5 March 2026
- was granted 15,262 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- ▼ sold on the open market 1,424 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- ▼ sold on the open market 2,543 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- ▼ sold on the open market 2,220 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- exercised options over 718 shares of GeneDx HoldingsSEC Form 43 March 2026Class A Common Stock · traded 1 March 2026 · filed 3 March 2026
- ▼ sold on the open market 287 shares of GeneDx HoldingsSEC Form 43 March 2026Class A Common Stock · traded 2 March 2026 · filed 3 March 2026
- exercised options over 718 shares of GeneDx Holdings (a derivative holding)SEC Form 43 March 2026Restricted Stock Unit · traded 1 March 2026 · filed 3 March 2026
- exercised options over 718 shares of GeneDx Holdings (a derivative holding)SEC Form 43 March 2026Restricted Stock Unit · traded 1 March 2026 · filed 3 March 2026
- exercised options over 718 shares of GeneDx HoldingsSEC Form 43 March 2026Class A Common Stock · traded 1 March 2026 · filed 3 March 2026
- ▼ sold on the open market 287 shares of GeneDx HoldingsSEC Form 43 March 2026Class A Common Stock · traded 2 March 2026 · filed 3 March 2026
- exercised options over 754 shares of GeneDx HoldingsSEC Form 42 February 2026Class A Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 315 shares of GeneDx HoldingsSEC Form 42 February 2026Class A Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 2 shares of GeneDx HoldingsSEC Form 42 February 2026Class A Common Stock · traded 29 January 2026 · filed 2 February 2026
- exercised options over 754 shares of GeneDx Holdings (a derivative holding)SEC Form 42 February 2026Restricted Stock Unit · traded 29 January 2026 · filed 2 February 2026
- exercised options over 754 shares of GeneDx Holdings (a derivative holding)SEC Form 42 February 2026Restricted Stock Unit · traded 29 January 2026 · filed 2 February 2026
- exercised options over 754 shares of GeneDx HoldingsSEC Form 42 February 2026Class A Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 315 shares of GeneDx HoldingsSEC Form 42 February 2026Class A Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 2 shares of GeneDx HoldingsSEC Form 42 February 2026Class A Common Stock · traded 29 January 2026 · filed 2 February 2026
- exercised options over 7,197 shares of GeneDx Holdings (a derivative holding)SEC Form 418 December 2025Restricted Stock Unit · traded 16 December 2025 · filed 18 December 2025
- exercised options over 7,197 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 131 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 366 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 951 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 215 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 334 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 578 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 699 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 331 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 97 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 26 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 127 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- exercised options over 2,462 shares of GeneDx Holdings (a derivative holding)SEC Form 411 December 2025Restricted Stock Unit · traded 9 December 2025 · filed 11 December 2025
- exercised options over 2,462 shares of GeneDx HoldingsSEC Form 411 December 2025Class A Common Stock · traded 9 December 2025 · filed 11 December 2025
- ▼ sold on the open market 1,266 shares of GeneDx HoldingsSEC Form 411 December 2025Class A Common Stock · traded 9 December 2025 · filed 11 December 2025
- exercised options over 717 shares of GeneDx Holdings (a derivative holding)SEC Form 43 December 2025Restricted Stock Unit · traded 1 December 2025 · filed 3 December 2025
- exercised options over 717 shares of GeneDx HoldingsSEC Form 43 December 2025Class A Common Stock · traded 1 December 2025 · filed 3 December 2025
- ▼ sold on the open market 377 shares of GeneDx HoldingsSEC Form 43 December 2025Class A Common Stock · traded 1 December 2025 · filed 3 December 2025
- exercised options over 753 shares of GeneDx Holdings (a derivative holding)SEC Form 431 October 2025Restricted Stock Unit · traded 29 October 2025 · filed 31 October 2025
- exercised options over 753 shares of GeneDx HoldingsSEC Form 431 October 2025Class A Common Stock · traded 29 October 2025 · filed 31 October 2025
- ▼ sold on the open market 388 shares of GeneDx HoldingsSEC Form 431 October 2025Class A Common Stock · traded 29 October 2025 · filed 31 October 2025
- exercised options over 1,246 shares of GeneDx Holdings (a derivative holding)SEC Form 41 October 2025Employee Stock Option (Right to Buy) · traded 30 September 2025 · filed 1 October 2025
- exercised options over 1,246 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 344 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 387 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 2,715 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 2,152 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 421 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 520 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 70 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- exercised options over 7,197 shares of GeneDx Holdings (a derivative holding)SEC Form 418 September 2025Restricted Stock Unit · traded 16 September 2025 · filed 18 September 2025
- exercised options over 7,197 shares of GeneDx HoldingsSEC Form 418 September 2025Class A Common Stock · traded 16 September 2025 · filed 18 September 2025
- ▼ sold on the open market 3,728 shares of GeneDx HoldingsSEC Form 418 September 2025Class A Common Stock · traded 16 September 2025 · filed 18 September 2025
- exercised options over 7,197 shares of GeneDx HoldingsSEC Form 418 September 2025Class A Common Stock · traded 16 September 2025 · filed 18 September 2025
- exercised options over 2,462 shares of GeneDx Holdings (a derivative holding)SEC Form 411 September 2025Restricted Stock Unit · traded 9 September 2025 · filed 11 September 2025
- exercised options over 2,462 shares of GeneDx HoldingsSEC Form 411 September 2025Class A Common Stock · traded 9 September 2025 · filed 11 September 2025
- ▼ sold on the open market 1,266 shares of GeneDx HoldingsSEC Form 411 September 2025Class A Common Stock · traded 9 September 2025 · filed 11 September 2025
- ▼ sold on the open market 6 shares of GeneDx HoldingsSEC Form 411 September 2025Class A Common Stock · traded 9 September 2025 · filed 11 September 2025
- exercised options over 717 shares of GeneDx Holdings (a derivative holding)SEC Form 43 September 2025Restricted Stock Unit · traded 1 September 2025 · filed 3 September 2025
- exercised options over 717 shares of GeneDx HoldingsSEC Form 43 September 2025Class A Common Stock · traded 1 September 2025 · filed 3 September 2025
- ▼ sold on the open market 378 shares of GeneDx HoldingsSEC Form 43 September 2025Class A Common Stock · traded 2 September 2025 · filed 3 September 2025
- exercised options over 753 shares of GeneDx Holdings (a derivative holding)SEC Form 431 July 2025Restricted Stock Unit · traded 29 July 2025 · filed 31 July 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.